JFS Wealth Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$658 Sell
41
-105
-72% -$1.74K ﹤0.01% 1906
2026
Q1
$2.7K Sell
146
-703
-83% -$12.3K ﹤0.01% 1422
2025
Q4
$13.2K Sell
849
-27
-3% -$386 ﹤0.01% 881
2025
Q3
$12.8K Sell
876
-57
-6% -$846 ﹤0.01% 825
2025
Q2
$14.4K Buy
933
+125
+15% +$1.85K ﹤0.01% 744
2025
Q1
$12K Sell
808
-273
-25% -$3.83K ﹤0.01% 819
2024
Q4
$14.3K Buy
1,081
+120
+12% +$1.65K ﹤0.01% 745
2024
Q3
$13.7K Hold
961
﹤0.01% 748
2024
Q2
$12.4K Hold
961
﹤0.01% 727
2024
Q1
$13.3K Sell
961
-4
-0.4% -$58 ﹤0.01% 729
2023
Q4
$13.8K Hold
965
﹤0.01% 686
2023
Q3
$14.9K Hold
965
﹤0.01% 611
2023
Q2
$15.2K Sell
965
-254
-21% -$4.16K ﹤0.01% 601
2023
Q1
$20.1K Sell
1,219
-183
-13% -$2.92K ﹤0.01% 536
2022
Q4
$21.9K Sell
1,402
-9,046
-87% -$126K ﹤0.01% 517
2022
Q3
$136K Buy
10,448
+145
+1% +$2.02K 0.01% 255
2022
Q2
$145K Sell
10,303
-521
-5% -$7.44K 0.02% 248
2022
Q1
$155K Sell
10,824
-1,362
-11% -$20K 0.01% 253
2021
Q4
$166K Buy
12,186
+1,131
+10% +$15.9K 0.02% 246
2021
Q3
$181K Hold
11,055
0.02% 228
2021
Q2
$186K Buy
11,055
+1,845
+20% +$31.4K 0.03% 172
2021
Q1
$168K Buy
9,210
+771
+9% +$13.9K 0.03% 153
2020
Q4
$154K Buy
8,439
+818
+11% +$14.4K 0.03% 156
2020
Q3
$136K Buy
7,621
+623
+9% +$11.3K 0.03% 158
2020
Q2
$125K Buy
6,998
+363
+5% +$6.52K 0.03% 160
2020
Q1
$101K Buy
6,635
+1,456
+28% +$26.4K 0.03% 171
2019
Q4
$102K Hold
5,179
0.03% 194
2019
Q3
$89K Buy
5,179
+2,281
+79% +$39.4K 0.02% 197
2019
Q2
$51K Hold
2,898
0.01% 238
2019
Q1
$59K Buy
2,898
+346
+14% +$6.96K 0.02% 219
2018
Q4
$43K Buy
+2,552
New +$43.1K 0.01% 238

Other funds holding TAK